Cell Imaging Technology - Healthcare Provider Site细胞成像技术-医疗保健提供者的网站.pptVIP

下载本文档

7
0
约8.2千字
约 35页
2018-06-30 发布于浙江
举报
版权申诉

Cell Imaging Technology - Healthcare Provider Site细胞成像技术-医疗保健提供者的网站.ppt

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Cell Imaging Technology - Healthcare Provider Site细胞成像技术-医疗保健提供者的网站

Percent Change in [18F]FHBG Accumulation and Tumor/BKGD [18F]FHBG Post CTL Infusion ? Multimodality Imaging Approaches Should Help Transition from Pre-Clinical to Clinical Non-invasive Cell Imaging Studies ? Direct Labeling and Reporter Gene Based Imaging Strategies are Available for Monitoring Therapeutic Cell Biodistribution in Patients ? Reporter Gene Based Techniques Allow Imaging Biodistribution as Well as Survival and Status ? Incorporating Non-Invasive Imaging Into Cell Therapy Trials Should Help Optimize Protocols and Predict Efficacy or Potential Adverse Effects Summary Future Directions Acknowledgements Stanford University Sanjiv Gambhir Multimodality Imaging Group Nuclear Medicine Clinic Cyclotron City of Hope National Medical Center Michael Jensen Group UCLA Medical Center Dept of Mol Med Pharmacology Nuclear Medicine Clinic Cyclotron Funding National Cancer Institute ICMIC p50 R01 Patient Volunteers * * * * Ewing’s Leukapheresis, separation of mononuclear cells and activation of autologous T cells followed by treatment with human IL-2 to expand Electroporation of a plasmid construct containing the IL-13 Zetakine (IL-13R?2 receptor is over-expressed on Glioma cells relative to normal brain) under the control of a modified human Elongation Factor-1? promoter and HSV1-tk under the control of the CMV immediate/early promoter into CD8+ CTLs, followed by expansion of clones resistant to Hygromycin Confirmed the clones were positive for IL-13 zetakine, CD8 and TCR?/?, had a single copy of the plasmid vector DNA, were dependent on IL-2 for in vitro expansion, and susceptible to Ganciclovir induced cell death Upon recurrence, patient glioma tumors were surgically removed Autologous genetically engineered CTLs were infused into the tumor resection site in 12 sessions increasing from 107 to 108 cells depending on patient tolerance * * Molecular Imaging of Therapeutic Cells: Pre-Clinical and Clinical Studies Shahriar Yaghoubi, Ph.D. Chief Scientific Office